Trials / Conditions / Crohn's Disease (CD)

Crohn's Disease (CD)

19 registered clinical trials studyying Crohn's Disease (CD) — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participa NCT07528040	Shanghai 10th People's Hospital	—
Recruiting	Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study NCT07522528	University of Glasgow	N/A
Recruiting	Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD) NCT07337902	University of North Carolina, Chapel Hill	N/A
Recruiting	Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis NCT07524244	Fuller Research Foundation	N/A
Not Yet Recruiting	Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease NCT07309744	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	EARLY_Phase 1
Recruiting	Zymfentra (Infliximab-dyyb) REal World Cohort STudy NCT07237516	University of North Carolina, Chapel Hill	—
Recruiting	Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in S NCT07078994	Biocad	Phase 2
Recruiting	A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) NCT04779320	Takeda	Phase 3
Completed	The Impact of Time Restricted Feeding in Crohn's Disease NCT04271748	Weill Medical College of Cornell University	N/A
Active Not Recruiting	Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn NCT04524611	AbbVie	Phase 3
Completed	A Real-world Study of Imraldi® Use NCT04089514	Biogen	—
Completed	Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease NCT03801928	Pfizer	—
Completed	Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Diseas NCT02778464	The Royal Wolverhampton Hospitals NHS Trust	—
Terminated	UCB Cimzia Pregnancy Follow-up Study NCT02775656	UCB BIOSCIENCES, Inc.	—
Completed	A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitini NCT02782663	AbbVie	Phase 2
Completed	Fecal Microbiota Transplantation in Pediatric Patients NCT02108821	Children's Mercy Hospital Kansas City	Phase 1
Completed	Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D NCT01877577	University of California, San Francisco	N/A
Completed	Anal Human Papillomavirus in Inflammatory Bowel Disease Study NCT01364896	University of Pittsburgh	—
Completed	Cognition and Emotion in the SII and IBD NCT01095042	University Hospital, Grenoble	N/A